Last price paid | 0.16 | |
Change | +6.67% [ +0.01 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 28.05.2024 17:20 |
Fixing | n.a. |
Settlement date | 15.05.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +37.50% |
Year to date (YTD) | -51.52% |
1 month | -27.27% |
3 months | -48.39% |
1 year | +45.45% |
3 years | n.a. |
Issue price | 0.12 |
Underlying price on issue | 46.20 |
Premium | 0.03% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1250732992 |
Symbol | IBSWEZ |
Security | 125073299 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Basilea Pharmaceu N, CH0011432447 |
Underlying ISIN | CH0011432447 |
Funding level | 50.090800 |
Stop-loss level | 48.177000 |
Distance to stop-loss level | 11.13% |
Long/Short type | Short |
Subscription ratio | 50.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 11.05.2023 |
Premium | 3.47% |
Premium p.a. | n.a. |
Leverage | 5.25 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 6.740800 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Lonza Group | 484.20 |
UBS | 28.04 |
Partners Group Ho... | 1'197.00 |
KUEHNE & NAGEL | 249.50 |
Holcim | 79.30 |